As of 2024-12-12, the Fair Value of TCR2 Therapeutics Inc (TCRR) is -20.77 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.48 USD, the upside of TCR2 Therapeutics Inc is -1,503.43%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 5Y Avg | |
| Net income | -24.25 | -47.60 | -67.12 | -99.81 | -151.82 | -78.12 |
| YoY growth | -85.54% | -96.29% | -41.01% | -48.70% | -52.12% | -64.73% |
| Market Cap (mil) | 58.11 |
| P/E | |
| Forward P/E |
| EPS | -4.15 |
| Avg earnings growth rate | -64.73% |
| TTM earnings | -163.10 |